.jpg?format=webp&width=780)
This study aimed to refine the incidence rate of inflammatory myopathies (IM), rare systemic diseases characterized by muscle inflammation and weakness. The research utilized the 2017 ACR/EULAR IM classification criteria and a quadruple source capture-recapture method over a 6-year period in Alsace, France, a region with good access to healthcare and accredited IM referral centers. Data from multiple sources were analyzed, and a total of 106 IM patients were identified out of 1742 potential cases. The study found an incidence rate of 8.22 new cases per million people per year. The research highlights the systemic nature of IM and provides an accurate estimation of its incidence.
Like
Save
Share